… to be immunogenic in conferring broad-spectrum passive protection to neonatal mice against
… Altogether, these findings suggest that POMVs can be used as a potent vaccine candidate …

… as a nanoparticle that enables multivalent antigenic display. Other vaccine candidates have
… Although varying levels of antigen-adjuvant interactions did not affect mice immunogenicity …

… The objective was to develop a multi-epitope vaccine against the novel coronavirus (SARS-CoV-2);
we selected S protein due to height antigenic and conserved characteristics. As a …

… subunit vaccine is the Lyme recombinant OspA vaccine (Recombitek Lyme, Boehringer
Ingelheim) and the Lyme … In particular, the immunogenicity of distemper virus vaccines may be …

… Borrelia burgdorferi is the causative agent of Lyme disease, and outer surface protein …
OspA-encoding lipid nanoparticles loaded mRNA vaccine was fabricated, and its immunogenicity …

… vaccine formulations for prevention of a specific disease. The results of our systematic review
could influence future vaccine … aluminium adjuvants on the immunogenicity is based on the …

… Next, we compared the immunogenicity of 500 ng of A5 peptide admixed with CPQ or other
vaccine … For Ag screening, multivalent vaccines composed of peptides with the same MHC-I …

… immunogenic in rabbits and human adults, instead in human infants the 20-mer vaccine was
significantly more immunogenic … GSK in their multivalent pneumococcal conjugate vaccine …

… book of ICLB2022, the 16th edition of the International Conference on Lyme borreliosis and
… and from diagnostics to prevention of Lyme borreliosis as well as other tick-borne diseases. …

… These vaccines tend to be less immunogenic than MLV vaccines, so … No vaccine against
Lyme disease provides complete … , OspA vaccine and another chimaeric recombinant vaccine …